Business Description
Better Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US08773T1043
Description
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.46 | |||||
| Equity-to-Asset | -0.93 | |||||
| Debt-to-Equity | -1.44 | |||||
| Debt-to-EBITDA | -0.54 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -84 | |||||
| 3-Year EPS without NRI Growth Rate | -90.4 | |||||
| 3-Year FCF Growth Rate | -50 | |||||
| 3-Year Book Growth Rate | 66.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.8 | |||||
| 9-Day RSI | 24.35 | |||||
| 14-Day RSI | 27.05 | |||||
| 6-1 Month Momentum % | -89.19 | |||||
| 12-1 Month Momentum % | -98.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.57 | |||||
| Quick Ratio | 0.57 | |||||
| Cash Ratio | 0.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | -691.86 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -182.93 | |||||
| ROIC % | -317.61 | |||||
| ROC (Joel Greenblatt) % | -25053.3 | |||||
| ROCE % | -642.62 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.27 | |||||
| EV-to-EBITDA | -0.3 | |||||
| EV-to-FCF | -0.29 | |||||
| Earnings Yield (Greenblatt) % | -370.37 | |||||
| FCF Yield % | -6462.5 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BTTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Better Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.15 | ||
| Beta | 0 | ||
| Volatility % | 161.56 | ||
| 14-Day RSI | 27.05 | ||
| 14-Day ATR ($) | 0.008842 | ||
| 20-Day SMA ($) | 0.009997 | ||
| 12-1 Month Momentum % | -98.44 | ||
| 52-Week Range ($) | 0.005 - 1.35 | ||
| Shares Outstanding (Mil) | 54.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Better Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Better Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Better Therapeutics Inc Frequently Asked Questions
What is Better Therapeutics Inc(BTTX)'s stock price today?
The current price of BTTX is $0.01. The 52 week high of BTTX is $1.35 and 52 week low is $0.01.
When is next earnings date of Better Therapeutics Inc(BTTX)?
The next earnings date of Better Therapeutics Inc(BTTX) is 2024-05-10 Est..
Does Better Therapeutics Inc(BTTX) pay dividends? If so, how much?
Better Therapeutics Inc(BTTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers